Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis.

MLA

Jiang, Yawen, et al. “Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis.” Applied Health Economics and Health Policy, vol. 21, no. 3, May 2023, pp. 489–99. EBSCOhost, https://doi.org/10.1007/s40258-022-00784-3.

APA

Jiang, Y., Jiang, S., Li, L., Shi, S., Li, M., & Si, L. (2023). Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis. Applied Health Economics and Health Policy, 21(3), 489–499. https://doi.org/10.1007/s40258-022-00784-3

Chicago

Jiang, Yawen, Shan Jiang, Limin Li, Si Shi, Mincai Li, and Lei Si. 2023. “Cost Effectiveness of Denosumab for Secondary Prevention of Osteoporotic Fractures Among Postmenopausal Women in China: An Individual-Level Simulation Analysis.” Applied Health Economics and Health Policy 21 (3): 489–99. doi:10.1007/s40258-022-00784-3.